Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

2017 Annual Report: Top 10 Pipelines

There was a significant drop-off in NME approvals by FDA in 2016, but there were not enough new drug applications with user fee goals to reach the lofty 2015 total.

Read More »

Healthcare Agency Roundtable 2016

Management from 2016 Manny Award winners and finalists weigh in on various industry topics presented to them by Med Ad News.

Read More »

2016 Annual Report: Top 50 Companies – Pipelines & Pricing

The amount of new drug approvals in 2015 was the FDA’s highest total since 1950 due in part to revamped pipelines, but a tough future looms as the grumblings over pricing have risen to a roar.

Read More »

2016 Annual Report: Top 200 Medicines

AbbVie’s biologic therapy Humira for autoimmune diseases was the worldwide prescription-drug sales leader in 2015 for the fourth consecutive calendar term.

Read More »

2016 Annual Report: State of the Bio Industry

The outlook remains bright due to a favorable regulatory arena, support for biopharma-friendly legislation and development incentives, expanding scientific opportunities in key therapeutic areas such as immuno-oncology, and big pharma’s continued push to obtain innovation.

Read More »

2016 Annual Report: Healthcare Communications Agencies Overview – In Good Health

Long-established healthcare communications agencies in 2015 saw their businesses expand, and relative newcomers continued to find their stride.

Read More »

2016 Annual Report: Top 10 Pipelines

The pharma industry’s R&D concentration has been shifting towards specialty therapy areas as research and development returns decline for some leaders.

Read More »

Healthcare Agency Roundtable 2015

Executives from the 2015 and 2014 Manny Award winners and finalists share their views on a variety of industry-related topics.

Read More »

2015 Annual Report: Top 50 Companies Overview – Making Progress

The top pharmaceutical companies are blurring the lines with biotech and have been engaging in many collaborations, acquisitions, and restructuring plans in the past year.

Read More »

2015 Annual Report: Top 200 Medicines

Humira during 2014 remained the world’s best-selling prescription medicine; Sovaldi vaulted into second place in its first full year on the market; Harvoni is challenging Humira for the 2015 sales crown.

Read More »

2015 Annual Report: Top 100 Biotechnology Companies – The Acquisition Game

The U.S. biotechnology arena is undergoing a record-breaking M&A cycle for the industry. After generating M&A activity valued at $235 billion during 2014, the U.S. biotech sector produced more than $100 billion in deals during first-quarter 2015.

Read More »

2015 Annual Report: Healthcare Communications Agencies Overview – Growth In Unexpected Places

As the pipelines of their pharmaceutical and biotech clients continue to yield new drugs for patients, agencies are also seeing their business grow.

Read More »

2015 Annual Report: Top 10 Pipelines

Biologic medicines and immunotherapy are front and center amongst many of the R&D strategies and platforms for the industry’s leading developers.

Read More »

2014 Annual Report: Top 50 Companies Overview – Back From The Brink

The industry’s patent cliffs have become less steep, but the Affordable Care Act will give pharma new challenges.

Read More »

2014 Annual Report: Healthcare Communications Agencies Overview – Change, And Change Again

Fluidity was the state of pharmaceutical advertising in 2013, as agencies shifted their operations, personnel, and tactics to meet the needs of their clients, driven by the pace of digital.

Read More »

Drug Delivery Review And Outlook

The worldwide drug-delivery arena is growing each year as the increasing aging population is in need of improved methods of administration for products and therapies.

Read More »

Global Contract Manufacturing Companies: Pharmaceutical And Biotechnology

From big pharma to smaller specialty entities, contract manufacturing serves as a strategy for various industry players.

Read More »

OTC Review And Outlook

The global market for consumer-care products generated slower growth in 2010 than during the previous year, partially because of a weaker flu season in North America and Europe.

Read More »

M&A, Partnerships And Collaborations

Big Pharma started the new decade where it left off in 2009 by continuing to conduct a flurry of deals amongst each other and with many other types of companies throughout the healthcare industry.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

April 2017 Focus: Agency Profiles, Manny Awards and more!

Subscribe

Ad Right Bottom

Password Reset
Please enter your e-mail address. You will receive a new password via e-mail.

Main Navigation